We’re bringing together industry, government, regulators, patients and the NHS to remove barriers and accelerate the introduction of ground-breaking new treatments and diagnostics which can transform care.
The AAC supports all types of innovations: medicines, diagnostics, devices, digital products, pathway changes and new workforce models.
Matt Whitty, Director of Innovation, Research and Life Sciences, and Chief Executive of the Accelerated Access Collaborative (AAC) introduces the AAC’s Our Year in focus 2019/20 report.
The report provides a summary of the AAC’s achievements in 2019/20. Highlighting how over 700,000 patients have been provided with access to proven health and care innovations supported by the AAC, resulting in estimated patient benefits of over 12,000 fewer hospital admissions and 125,000 fewer days spent in hospital. Across the AAC programmes this work has saved the NHS over £50million.
The NHS has a long-standing history of innovation since it was founded in 1948, which has been a crucial factor in transforming the healthcare industry. From pioneering procedures such as intra-ocular lens implants and total hip replacements, to critical technologies like computerised tomography (CT) and magnetic resonance imaging (MRI), the NHS has always been at the […]
